The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2025 | Reveal-MM: retrospective evaluation of healthcare patterns in the years preceding myeloma diagnosis
Faith Davies, MD, MRCP, MRCPath, FRCPath, NYU Langone, New York, NY, discusses the Reveal-MM study, a US claims-based case-control study that retrospectively evaluated variables in early assessment and landmark trends in multiple myeloma (MM). The investigation highlighted that patients exhibit distinct patterns of healthcare utilization in the year prior to their myeloma diagnosis. Dr Davies notes that this data could be used to model patient presentation and identify those at risk of developing myeloma using artificial intelligence (AI), enabling earlier intervention and potentially improving patient outcomes. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
